Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Lilly’s breast cancer drug abemaciclib shows promising results in phase 3 trial Indianapolis-based pharmaceutical giant Lilly has announced positive outcomes from its phase 3 clinical trial, MONARCH 2, involving its… bypharmanewsdailyMarch 22, 2017
